ERAMET (ERA.PA EURONEXT) -20% intraday 20 Feb 2026: capital increase raises risk

The sell-off is immediate: ERA.PA stock plunged to €48.30, down -20.03% intraday on 20 Feb 2026 after management announced a €500.00 million capital increase and asset disposals. Volume accelerated to 56,732 shares versus a 50-day average near 83,458, pushing the share well below the 50-day average of €65.02. Traders are pricing near-term dilution and a weaker 2025 earnings outlook, while investors must weigh balance-sheet relief against persistent operating losses and high leverage.

Intraday movers and the catalyst: ERA.PA stock reaction

ERAMET S.A. (ERA.PA) opened at €46.00 and traded between €46.00 and €48.62 before settling near €48.30, a drop of €12.10 from the previous close of €60.40. The immediate trigger was a company plan to raise €500.00 million and sell assets after FY2025 results showed a 54.00% fall in adjusted EBITDA and a net loss of €370.00 million, according to company slides and Reuters coverage. Market reaction amplified when analysts described FY2025 as ‘disastrous’, prompting heavy intraday selling and a relVolume of 5.17. Read the Reuters and company briefings for background: Reuters report on Feb 18, 2026 and the FY2025 slides summary on Investing.com Investing.com slides summary.

Fundamentals and valuation snapshot for ERA.PA stock

ERAMET reports trailing EPS of -3.37 and a negative P/E of -13.68, reflecting losses and one-off items from 2025. Key ratios show price/book 1.29, debt/equity 2.37, and cash per share €26.06 versus book value per share €61.47. Market cap stands at roughly €1.32 billion with 28,579,508 shares outstanding. These fundamentals explain why investors demanded a capital increase to shore up equity and reduce net debt near €1.90 billion reported in the FY slides.

Meyka AI grade and model view

Meyka AI rates ERA.PA with a score out of 100: 60.74 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s grade reflects a balance between tangible assets (book value per share €61.47) and weak profitability metrics. These grades are not guaranteed and we are not financial advisors.

Technical and trading signals for ERA.PA stock

The technical picture shows momentum to the downside. RSI sits at 39.61, MACD histogram at -1.69, and ADX at 31.90 signalling a strong trend. Price is trading below the 50-day moving average €65.02 and the 200-day €55.35, and MFI at 18.52 signals oversold conditions. Intraday volatility is high; ATR equals €3.83. Traders should note a wide Bollinger band range (lower €51.25, middle €69.27) and heavy volume spikes that indicate forced selling rather than measured profit-taking.

Catalysts, risks and sector context

Immediate catalysts include the €500.00 million rights issue, announced asset sales and management’s recovery plan. Key risks: dilution from the capital raise, execution risk on asset disposals, cyclical metal prices (nickel and manganese), and high leverage. The Basic Materials sector has shown resilience YTD (sector YTD +6.72%), but ERAMET’s 2025 operational hit leaves it lagging peers. Positive catalysts would be faster-than-expected asset disposals, clearer EBITDA guidance and metal price support.

Price targets and outlook: ERA.PA stock forecast scenarios

Meyka AI’s forecast model projects a range of outcomes: monthly €65.90, quarterly €83.78, yearly €34.42, and 3-year €9.89. Scenario targets aligned to those outputs: a conservative near-term support target €40.00, base-case 12-month target €50.00, and recovery/bull target €70.00 if asset sales and margins improve. Current price €48.30 sits between the conservative and base-case targets. Investors should note the model divergence — short-term technical relief can coexist with medium-term downside if earnings fail to stabilize.

Final Thoughts

Key takeaways: ERA.PA stock fell -20.03% intraday to €48.30 on 20 Feb 2026 after ERAMET announced a €500.00 million capital increase and asset sales to repair the balance sheet. Fundamentals show negative EPS -3.37, high leverage (debt/equity 2.37) and book value support at €61.47 per share. Meyka AI’s forecast model projects a yearly level of €34.42, implying a -28.75% downside versus today’s price; the model also shows a monthly projection of €65.90, reflecting short-term scenario upside. Meyka AI’s forecast model projects outcomes across scenarios and is model-based projection and not a guarantee. Given contrasts between tangible assets and weak cash flow generation, our Meyka grade of B (60.74) suggests a HOLD bias until the capital increase completes and asset-sale execution becomes clearer. Use tight risk controls, monitor the rights issue terms and follow quarterly updates before re-entering sizable positions. Meyka AI provides this analysis as an AI-powered market analysis platform; this is informational and not personal financial advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.